S&P 500   4,689.75 (+0.06%)
DOW   35,667.84 (-0.14%)
QQQ   398.94 (+0.28%)
AAPL   174.61 (+2.00%)
MSFT   332.73 (-0.65%)
FB   331.05 (+2.55%)
GOOGL   2,946.33 (+0.03%)
AMZN   3,527.18 (+0.11%)
TSLA   1,064.67 (+1.23%)
NVDA   320.65 (-1.12%)
BABA   125.91 (+0.29%)
NIO   35.08 (+5.92%)
CGC   11.13 (+4.61%)
AMD   145.18 (+0.23%)
GE   98.53 (+1.00%)
MU   86.01 (+0.21%)
T   23.20 (+0.52%)
F   19.86 (-0.50%)
DIS   153.34 (+1.68%)
PFE   51.47 (-0.48%)
AMC   33.01 (+6.35%)
ACB   6.69 (+4.86%)
BA   211.71 (+1.38%)
S&P 500   4,689.75 (+0.06%)
DOW   35,667.84 (-0.14%)
QQQ   398.94 (+0.28%)
AAPL   174.61 (+2.00%)
MSFT   332.73 (-0.65%)
FB   331.05 (+2.55%)
GOOGL   2,946.33 (+0.03%)
AMZN   3,527.18 (+0.11%)
TSLA   1,064.67 (+1.23%)
NVDA   320.65 (-1.12%)
BABA   125.91 (+0.29%)
NIO   35.08 (+5.92%)
CGC   11.13 (+4.61%)
AMD   145.18 (+0.23%)
GE   98.53 (+1.00%)
MU   86.01 (+0.21%)
T   23.20 (+0.52%)
F   19.86 (-0.50%)
DIS   153.34 (+1.68%)
PFE   51.47 (-0.48%)
AMC   33.01 (+6.35%)
ACB   6.69 (+4.86%)
BA   211.71 (+1.38%)
S&P 500   4,689.75 (+0.06%)
DOW   35,667.84 (-0.14%)
QQQ   398.94 (+0.28%)
AAPL   174.61 (+2.00%)
MSFT   332.73 (-0.65%)
FB   331.05 (+2.55%)
GOOGL   2,946.33 (+0.03%)
AMZN   3,527.18 (+0.11%)
TSLA   1,064.67 (+1.23%)
NVDA   320.65 (-1.12%)
BABA   125.91 (+0.29%)
NIO   35.08 (+5.92%)
CGC   11.13 (+4.61%)
AMD   145.18 (+0.23%)
GE   98.53 (+1.00%)
MU   86.01 (+0.21%)
T   23.20 (+0.52%)
F   19.86 (-0.50%)
DIS   153.34 (+1.68%)
PFE   51.47 (-0.48%)
AMC   33.01 (+6.35%)
ACB   6.69 (+4.86%)
BA   211.71 (+1.38%)
S&P 500   4,689.75 (+0.06%)
DOW   35,667.84 (-0.14%)
QQQ   398.94 (+0.28%)
AAPL   174.61 (+2.00%)
MSFT   332.73 (-0.65%)
FB   331.05 (+2.55%)
GOOGL   2,946.33 (+0.03%)
AMZN   3,527.18 (+0.11%)
TSLA   1,064.67 (+1.23%)
NVDA   320.65 (-1.12%)
BABA   125.91 (+0.29%)
NIO   35.08 (+5.92%)
CGC   11.13 (+4.61%)
AMD   145.18 (+0.23%)
GE   98.53 (+1.00%)
MU   86.01 (+0.21%)
T   23.20 (+0.52%)
F   19.86 (-0.50%)
DIS   153.34 (+1.68%)
PFE   51.47 (-0.48%)
AMC   33.01 (+6.35%)
ACB   6.69 (+4.86%)
BA   211.71 (+1.38%)
OTCMKTS:BCYP

Big Cypress Acquisition Stock Forecast, Price & News

$8.44
-2.01 (-19.23 %)
(As of 10/22/2021)
Add
Compare
Today's Range
$8.21
$12.90
50-Day Range
$8.44
$10.47
52-Week Range
$8.21
$12.90
Volume
15.34 million shs
Average Volume
160,982 shs
Market Capitalization
$124.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive BCYP News and Ratings via Email

Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter.


Big Cypress Acquisition logo

About Big Cypress Acquisition

Big Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.

Headlines

Big Cypress Acquisition Corp.
August 11, 2021 |  barrons.com
STMP Jul 2021 300.000 put
July 15, 2021 |  in.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BCYP
Employees
5
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$124.84 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/11/2014
Today
12/08/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

2.19 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -












Big Cypress Acquisition (OTCMKTS:BCYP) Frequently Asked Questions

Is Big Cypress Acquisition a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Big Cypress Acquisition in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Big Cypress Acquisition stock.
View analyst ratings for Big Cypress Acquisition
or view top-rated stocks.

What stocks does MarketBeat like better than Big Cypress Acquisition?

Wall Street analysts have given Big Cypress Acquisition a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Big Cypress Acquisition wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Big Cypress Acquisition's earnings last quarter?

Big Cypress Acquisition Corp. (OTCMKTS:BCYP) issued its quarterly earnings results on Tuesday, November, 11th. The technology company reported ($0.01) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.01). The technology company earned $0.31 million during the quarter, compared to the consensus estimate of $0.21 million.
View Big Cypress Acquisition's earnings history
.

How has Big Cypress Acquisition's stock been impacted by COVID-19 (Coronavirus)?

Big Cypress Acquisition's stock was trading at $0.0065 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BCYP stock has increased by 129,746.2% and is now trading at $8.44.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for BCYP?

2 analysts have issued 1 year price targets for Big Cypress Acquisition's shares. Their forecasts range from $16.50 to $18.00. On average, they anticipate Big Cypress Acquisition's stock price to reach $17.25 in the next twelve months. This suggests a possible upside of 104.4% from the stock's current price.
View analysts' price targets for Big Cypress Acquisition
or view top-rated stocks among Wall Street analysts.

Who are Big Cypress Acquisition's key executives?

Big Cypress Acquisition's management team includes the following people:

What other stocks do shareholders of Big Cypress Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Big Cypress Acquisition investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).

What is Big Cypress Acquisition's stock symbol?

Big Cypress Acquisition trades on the OTCMKTS under the ticker symbol "BCYP."

Who are Big Cypress Acquisition's major shareholders?

Big Cypress Acquisition's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Berkley W R Corp (3.69%), Periscope Capital Inc. (3.58%), Basso Capital Management L.P. (2.97%), Magnetar Financial LLC (2.19%), Mizuho Securities USA LLC (1.99%) and Millennium Management LLC (1.29%). Company insiders that own Big Cypress Acquisition stock include Big Cypress Holdings Llc, Ilan Katz, Jeffrey G Spragens and Samuel J Reich.
View institutional ownership trends for Big Cypress Acquisition
.

Which major investors are selling Big Cypress Acquisition stock?

BCYP stock was sold by a variety of institutional investors in the last quarter, including Basso Capital Management L.P., Picton Mahoney Asset Management, Periscope Capital Inc., Goldman Sachs Group Inc., and Citadel Advisors LLC.
View insider buying and selling activity for Big Cypress Acquisition
or view top insider-selling stocks.

Which major investors are buying Big Cypress Acquisition stock?

BCYP stock was acquired by a variety of institutional investors in the last quarter, including Magnetar Financial LLC, Beryl Capital Management LLC, Millennium Management LLC, Berkley W R Corp, Weiss Asset Management LP, Falcon Edge Capital LP, Mizuho Securities USA LLC, and TENOR CAPITAL MANAGEMENT Co. L.P.. Company insiders that have bought Big Cypress Acquisition stock in the last two years include Big Cypress Holdings Llc, Ilan Katz, Jeffrey G Spragens, and Samuel J Reich.
View insider buying and selling activity for Big Cypress Acquisition
or or view top insider-buying stocks.

How do I buy shares of Big Cypress Acquisition?

Shares of BCYP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Big Cypress Acquisition's stock price today?

One share of BCYP stock can currently be purchased for approximately $8.44.

How much money does Big Cypress Acquisition make?

Big Cypress Acquisition has a market capitalization of $124.84 million.

How many employees does Big Cypress Acquisition have?

Big Cypress Acquisition employs 5 workers across the globe.

What is Big Cypress Acquisition's official website?

The official website for Big Cypress Acquisition is www.bluecalypso.com.

Where are Big Cypress Acquisition's headquarters?

Big Cypress Acquisition is headquartered at 101 W. RENNER RD., RICHARDSON TX, 75082.

How can I contact Big Cypress Acquisition?

Big Cypress Acquisition's mailing address is 101 W. RENNER RD., RICHARDSON TX, 75082. The technology company can be reached via phone at 305-204-3338 or via email at [email protected].


This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.